Lv5
980 积分 2025-04-30 加入
A Second-Generation Route to the Cereblon Fragment of ARV-471, Vepdegestrant
6小时前
待确认
Approaches and Considerations for the Investigation and Synthesis of N-Nitrosamine Drug Substance-Related Impurities (NDSRIs)
10小时前
已完结
Cu-Catalyzed C–N Couplings with Benzilamide Ligands
1个月前
已完结
Development of a Commercial Manufacturing Process for Vepdegestrant, an Orally Bioavailable PROTAC Estrogen Receptor Degrader for the Treatment of Breast Cancer
1个月前
已完结
Optimizing the CHF6523 Isocoumarin Core Scaffold: From the Preclinical Stage to Large-Scale Production
2个月前
已完结
Enabling the First Scale-Up of the Selective HER2 Inhibitor BI-4142
3个月前
已完结
Development of the Late-Phase Manufacturing Process of ZPL389: Control of Process Impurities by Enhanced Process Knowledge
3个月前
已完结
A Concise Flow Synthesis of the IKZF2 Glue Degrader DKY709
4个月前
已完结
Development of a Manufacturing Process for S-892216 Part II: Improvements Toward Commercially Feasible Process
4个月前
已完结
Process Development for the Manufacture of a Topical Pan-Trk Inhibitor Incorporating Decarboxylative sp2–sp3 Cross-Coupling
4个月前
已完结
皖公网安备34019202002308
